Medscape: Skin adverse events rare after immunotherapy to treat skin cancers

Medscape highlighted University of Cincinnati research published in JAMA Dermatology that found certain skin adverse events were rare following immunotherapy treatments for certain skin cancers.

"Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors are commonly used drugs for the treatment of various cancers," said Pushkar Aggarwal, MD, corresponding author and medical resident/fellow in UC's College of Medicine. "Having knowledge regarding possible associated skin reactions is vital for clinicians to guide management of the skin reaction and whether an adjustment is needed for the PD-1/PD-L1 inhibitors."

The researchers reviewed adverse event reports for patients treated with PD-1 and PD-L1 treatments between January 2004 and May 2023 to identify whether significant signals exist between PD-1/PD-L1 inhibitors and skin tumors keratoacanthoma and cutaneous squamous cell carcinoma (cSCC).

"For both keratoacanthoma and cSCC, significant signals were found with PD-1/PD-L1 inhibitors," Aggarwal said. But, out of 158,000 cases in the review, the data showed only 43 patients developing keratocanthoma and 83 developing cSCC, which highlights the conditions are "relatively rare adverse events."

Aggarwal said case reports, case-control trials and randomized clinical trials are needed to confirm the results of this study.

Read the Medscape article.

Featured photo at top of metastatic melanoma cells. Photo/National Cancer Institute.

Related Stories

9965 Results
3

Camp aims to empower children, teens who stutter

July 17, 2024

A one-week, evidence-based program for children and teens who stutter at the University of Cincinnati will teach kids to communicate effectively, advocate for themselves and develop confidence about their communication abilities. Camp Dream. Speak. Live., which is coming to Cincinnati for the first time July 22-26, began in 2014 at the University of Texas at Austin. The Arthur M. Blank Center for Stuttering Education and Research at UT expects to serve more than 2,000 children at camps across the United States, Africa, Asia and Europe this year.

7

U.S. stroke survival is improving, but race still plays role

July 16, 2024

U.S. News & World Report, HealthDay and Real Health covered new research from the University of Cincinnati that found overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals.

8

Collaborative pianist and vocal coach Kirill Kuzmin joins CCM’s faculty

July 16, 2024

UC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Kirill Kuzmin to the college’s faculty of distinguished performing and media arts experts, researchers and educators. A Grammy-nominated collaborative pianist and vocal coach, Kuzmin begins his new role as Associate Professor of Opera/Vocal Coaching on Aug. 15, 2024.

10

Presidential challenge to UC: Join Ride Cincinnati to fight cancer

July 16, 2024

UC President Neville Pinto has again challenged every UC college and unit to send at least one rider to the September 14 Ride Cincinnati event to help fundraise for cancer research and cancer care. UC students ride free. Signup by July 31 for free UC-branded cycling jersey.